Investigating metastasis in colon cancer patients undergoing surgery
Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure
This study is testing how removing certain parts of the mesentery during colon cancer surgery affects the safety and outcomes for patients with tumors near the liver.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT04980287 on ClinicalTrials.gov |
What this trial studies
This observational study aims to define the incidence of mesogastrium metastasis in patients with colon cancer located at or near the hepatic flexure. It will analyze the safety and surgical outcomes of patients undergoing complete mesocolic excision with right gastroepiploic mesentery resection. Utilizing high-definition laparoscopy, the study seeks to improve understanding of the mesentery's role in colon cancer surgery and its impact on patient outcomes. The study builds on previous findings that suggest complete mesocolic excision can reduce recurrence rates and improve survival.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 75 with biopsy-proven colorectal carcinoma located at the hepatic flexure or transverse colon, who are undergoing complete mesocolic excision.
Not a fit: Patients with synchronous colorectal carcinoma, evidence of metastasis, or a history of colorectal cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance surgical techniques and outcomes for colon cancer patients, potentially leading to better survival rates.
How similar studies have performed: Previous studies on complete mesocolic excision have shown promising results in reducing recurrence rates and improving survival, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of colorectal carcinoma * Preoperative staging cT2-4aN0M0 or cTanyN+M0 * tumor located at hepatic flexure or transverse colon close to flexures * Undergoing complete mesocolic excision with right gastric mesentery resection * Patients have to be aware of the aim of the trial, and have signed the informed consent. Exclusion Criteria: * Synchronous colorectal carcinoma * Clinical evidence of metastasis * History of colorectal cancer or other malignant tumors * Preoperative staging cT1N0 or cT4bNany * Emergency procedure
Where this trial is running
Wuhan, Hubei
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Jichao Qin, M.D./Ph.D
- Email: jcqin@tjh.thmu.edu.cn
- Phone: 008613628683363
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.